Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Notes underwriting agrmnt
Inv. presentation
Quarterly results
Acq. announced
|
|
Vistagen Therapeutics, Inc. (VTGN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/28/2023 |
10-K
| Annual Report for the period ended March 31, 2023 |
| 06/23/2022 |
10-K
| Annual Report for the period ended March 31, 2022 |
| 06/29/2021 |
10-K
| Annual Report for the period ended March 31, 2021 |
| 06/29/2020 |
10-K
| Annual Report for the period ended March 31, 2020 |
| 06/25/2019 |
10-K
| Annual Report for the period ended March 31, 2019 |
| 06/26/2018 |
10-K
| Annual Report for the period ended March 31, 2018 |
| 06/28/2017 |
10-K
| Annual Report for the period ended March 31, 2017 |
| 06/24/2016 |
10-K
| Annual Report for the period ended March 31, 2016 |
| 06/29/2015 |
10-K
| Annual Report for the period ended March 31, 2015 |
| 06/25/2014 |
10-K
| Annual Report for the period ended March 31, 2014 |
| 07/18/2013 |
10-K
| Annual Report for the period ended March 31, 2013 |
| 07/02/2012 |
10-K
| Annual Report for the period ended March 31, 2012 |
| 03/31/2011 |
10-K
| Annual Report for the period ended December 31, 2010 |
| 08/04/2010 |
10-K/A
| Annual Report for the period ended December 31, 2009 [amend] |
| 03/17/2010 |
10-K
| Annual Report for the period ended December 31, 2009 |
| 03/31/2009 |
10-K
| Annual Report for the period ended December 31, 2008 |
|
|